José M Lou-Bonafonte1, Carmen Arnal, Jesús Osada. 1. Departamento de Farmacología y Fisiología, Facultad de Ciencias de Salud y del Deporte, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, Zaragoza, Spain.
Abstract
PURPOSE OF REVIEW: To summarize currently available information about the mechanisms involved in liver fat accumulation. RECENT FINDINGS: The contribution of functional genomics approaches, such as those represented by high-throughput analysis and genetically modified mice, may envision a complex network involving fatty acid, triglyceride and phospholipid metabolisms and lipid droplet dynamics. Likewise, it may pose an exquisite regulation exerted through insulin, glucocorticoids, thyroid hormones, transcription factors and microRNAs, orchestrated with sexual differences and able to respond to environmental factors such as nutritional or viral influences among others. SUMMARY: The information gathered will facilitate further research to complete gaps of interacting pieces among regulators and new contributing agents emerging from high-throughput analyses. With this new paradigm, new biomarkers able to discriminate the progression of hepatic steatosis into human steatohepatitis will eventually emerge, and hopefully new therapeutic approaches will be developed.
PURPOSE OF REVIEW: To summarize currently available information about the mechanisms involved in liver fat accumulation. RECENT FINDINGS: The contribution of functional genomics approaches, such as those represented by high-throughput analysis and genetically modified mice, may envision a complex network involving fatty acid, triglyceride and phospholipid metabolisms and lipid droplet dynamics. Likewise, it may pose an exquisite regulation exerted through insulin, glucocorticoids, thyroid hormones, transcription factors and microRNAs, orchestrated with sexual differences and able to respond to environmental factors such as nutritional or viral influences among others. SUMMARY: The information gathered will facilitate further research to complete gaps of interacting pieces among regulators and new contributing agents emerging from high-throughput analyses. With this new paradigm, new biomarkers able to discriminate the progression of hepatic steatosis into humansteatohepatitis will eventually emerge, and hopefully new therapeutic approaches will be developed.
Authors: Xiaodong Zhang; Xitao Xie; Bradlee L Heckmann; Alicia M Saarinen; Haiwei Gu; Rudolf Zechner; Jun Liu Journal: FASEB J Date: 2019-02-25 Impact factor: 5.834
Authors: C Lisa Kurtz; Emily E Fannin; Cynthia L Toth; Daniel S Pearson; Kasey C Vickers; Praveen Sethupathy Journal: Sci Rep Date: 2015-08-06 Impact factor: 4.379
Authors: Luis V Herrera-Marcos; Roberto Martínez-Beamonte; Manuel Macías-Herranz; Carmen Arnal; Cristina Barranquero; Juan J Puente-Lanzarote; Sonia Gascón; Tania Herrero-Continente; Gonzalo Gonzalo-Romeo; Víctor Alastrué-Vera; Dolores Gutiérrez-Blázquez; José M Lou-Bonafonte; Joaquín C Surra; María J Rodríguez-Yoldi; Agustín García-Gil; Antonio Güemes; Jesús Osada Journal: Sci Rep Date: 2022-01-19 Impact factor: 4.379